Top 50 Biotech Startup Investors in Spain (July 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Centre for the Development of Industrial Technology (CDTI)
VC Fund
|
27 | Spain, United States, France | Grant, Seed | Biotechnology, Health Care, Software | $157k–$16M |
|
Inveready
VC Fund
|
18 | Spain, United States, United Kingdom | Seed, Series A | Software, Biotechnology, Information Technology | $400k–$14M |
|
Criteria Venture Tech
VC Fund
|
15 | Spain, United States, United Kingdom | Seed, Series A | Software, Biotechnology, E-Commerce | $256k–$21M |
|
SODENA
VC Fund
|
14 | Spain, United Kingdom | Debt Financing, Seed | Health Care, Biotechnology, Manufacturing | $37k–$922k |
|
Clave Capital
VC Fund
|
14 | Spain, Chile, Switzerland | Seed, Series A, Venture - Series Unknown | Biotechnology, Health Care, Software | $462k–$16M |
|
Invivo Capital Partners
VC Fund
|
13 | Spain, France, Belgium | Seed, Series A | Biotechnology, Pharmaceutical, Health Care | $1.6M–$70M |
|
ENISA
VC Fund
|
12 | Spain, United States, France | Seed, Debt Financing, Pre-Seed | Software, Health Care, Artificial Intelligence | $66k–$2.1M |
|
Asabys Partners
VC Fund
|
11 | Spain, France, Belgium | Series A, Series B, Seed | Health Care, Biotechnology, Medical Device | $1.2M–$135M |
|
CDTI Innovación's INNVIERTE program
VC Fund
|
10 | Spain, Panama, Switzerland | Venture - Series Unknown, Seed | Biotechnology, Health Care, Medical | $266k–$16M |
|
Ysios Capital
VC Fund
|
10 | Spain, United States, Switzerland | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $3.8M–$135M |
|
Capital Cell
VC Fund
|
10 | Spain, France, United States | Equity Crowdfunding, Seed | Health Care, Biotechnology, Medical | $137k–$1.9M |
|
BeAble Capital
VC Fund
|
10 | Spain, Italy | Pre-Seed, Seed | Biotechnology, Manufacturing, Software | $124k–$1.2M |
|
Alta Life Sciences
VC Fund
|
9 | Spain, United States | Series A, Series B | Biotechnology, Health Care, Medical Device | $3M–$87M |
|
ICF Capital
VC Fund
|
9 | Spain, United States, Mexico | Debt Financing, Seed | Software, Health Care, Biotechnology | $110k–$6.9M |
|
Bullnet Capital
VC Fund
|
8 | Spain, United States, Mexico | Seed, Series A | Software, Information Technology, Manufacturing | $587k–$11M |
|
CRB Inverbío
VC Fund
|
7 | Spain, Italy, Mexico | Series A, Seed | Health Care, Medical, Biotechnology | $2.2M–$8.9M |
|
Xesgalicia
VC Fund
|
7 | Spain, Portugal | Seed, Pre-Seed | Software, Biotechnology, Pharmaceutical | $304k–$5.9M |
|
AdBio partners
VC Fund
|
6 | France, Spain, Belgium | Seed, Series A | Biotechnology, Health Care, Pharmaceutical | $2.2M–$37M |
|
SOSV
VC Fund
|
6 | United States, India, United Kingdom | Seed, Convertible Note, Pre-Seed | Biotechnology, Health Care, Software | |
|
BStartup
VC Fund
|
5 | Spain, Mexico, United States | Seed, Pre-Seed | Software, Information Technology, Artificial Intelligence | $110k–$2.2M |
|
Grow Venture Partners
VC Fund
|
5 | Spain | Seed, Pre-Seed, Venture - Series Unknown | Health Care, Biotechnology, Artificial Intelligence | $106k–$9.5M |
|
Gestion De Capital Riesgo Del Pais Vasco
VC Fund
|
5 | Spain, Ecuador | Seed, Series A | Biotechnology, Health Care, Medical | $213k–$14M |
|
Moira Capital Partners
VC Fund
|
5 | Spain | Private Equity, Venture - Series Unknown | Biotechnology, Apps, Water Purification | $5.5M–$18M |
|
Amadeus Capital Partners
VC Fund
|
4 | United Kingdom, United States, Spain | Seed, Series B, Series A | Software, Artificial Intelligence, Information Technology | $900k–$43M |
|
Angels Capital
VC Fund
|
4 | Spain, United States, Ireland | Seed, Angel, Pre-Seed | Software, E-Commerce, Health Care | $104k–$2.5M |
|
Clave Mayor
VC Fund
|
4 | Spain, Germany, United States | Seed, Series A | Software, Biotechnology, Medical | $262k–$8.9M |
|
CDTI
VC Fund
|
4 | Spain, United States, Mexico | Seed, Debt Financing | Software, Information Technology, Health Care | $274k–$2.6M |
|
Columbus Venture Partners
VC Fund
|
4 | Spain, United States, United Kingdom | Series B, Seed | Biotechnology, Health Care, Medical | $1.7M–$87M |
|
Seed Capital Bizkaia
VC Fund
|
4 | Spain, Mexico, Belgium | Seed, Series A | Software, Biotechnology, Health Care | $119k–$14M |
|
Nara Capital
VC Fund
|
4 | Spain | Seed, Venture - Series Unknown, Series A | Life Science, Biotechnology, Medical | $394k–$7.3M |
|
WA4STEAM
VC Fund
|
3 | Spain | Seed, Pre-Seed, Series A | Health Care, Biotechnology, Artificial Intelligence | $392k–$4.2M |
|
Cofides
VC Fund
|
3 | Spain, Ecuador | Debt Financing, Private Equity, Series B | Manufacturing, Health Care, Industrial | $219k–$105M |
|
Fitalent
VC Fund
|
3 | Spain | Seed, Series A | Biotechnology, Analytics, Health Care | $165k–$4.8M |
|
Pirate Impact
VC Fund
|
3 | Germany, Spain, Denmark | Seed, Series C | EdTech, E-Learning, Renewable Energy | $4M–$13M |
|
Union Square Ventures
VC Fund
|
3 | United States, United Kingdom, Canada | Series A, Series B, Seed | Software, Financial Services, FinTech | $2M–$40M |
|
European Investment Bank
VC Fund
|
3 | France, Germany, The Netherlands | Debt Financing, Post-IPO Debt | Biotechnology, Health Care, Energy | $16M–$658M |
|
Faber
VC Fund
|
3 | Portugal, United States, United Kingdom | Seed, Pre-Seed, Series A | Artificial Intelligence, Software, SaaS | $34k–$25M |
|
ICF - Institut Català de Finances
VC Fund
|
3 | Spain, Germany | Debt Financing, Seed | Health Care, Medical, Biotechnology | $1.7M–$44M |
|
Startupxplore
VC Fund
|
3 | Spain | Pre-Seed, Seed, Convertible Note | Artificial Intelligence, Health Care, Software | $111k–$870k |
|
AENU
VC Fund
|
3 | Germany, United States, United Kingdom | Seed, Series A, Series B | Renewable Energy, Software, CleanTech | $2.4M–$87M |
|
AVANTECA Partners
VC Fund
|
3 | Spain, Switzerland | Seed, Series A, Venture - Series Unknown | Biotechnology, Health Care, Security | $805k–$2.7M |
|
Buenavista Equity Partners
VC Fund
|
2 | Spain, Ecuador, Romania | Private Equity, Seed, Series A | Biotechnology, Health Care, Restaurants | $2.9M–$50M |
|
Gus Bertolo
Angel
|
2 | Spain | Seed | Software, Biotechnology, Artificial Intelligence | |
|
Alberto Hospital Marco
Angel
|
2 | Spain | Seed | SaaS, Software, Logistics | |
|
Kurma Partners
VC Fund
|
2 | France, Switzerland, Spain | Series A, Seed, Series B | Health Care, Biotechnology, Medical | $2.3M–$95M |
|
Josep Carreras Leukaemia Research Institute
VC Fund
|
2 | Spain | Seed | Life Science, Biotechnology | $3.4M–$7.3M |
|
Demium Capital
VC Fund
|
2 | Spain, Portugal, Poland | Pre-Seed, Seed, Series A | Software, FinTech, Health Care | $110k–$3.1M |
|
Grupo Ferrer Internacional
VC Fund
|
2 | Spain | Series A | Biotechnology, Wellness, Biopharma | |
|
EASO Ventures
VC Fund
|
2 | Spain, Switzerland | Seed, Venture - Series Unknown | Software, Health Care, Manufacturing | $54k–$5.3M |
|
Kinled Holding
VC Fund
|
2 | United Kingdom, United States, Switzerland | Seed, Series A | Biotechnology, Health Care, Software | $500k–$43M |
| Access all 437 investors in Spain Biotech startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
The Center for Industrial Technological Development (CDTI) is a public corporation under the Ministry of Economy and Competitiveness, which promotes innovation and technological development of Spanish companies. Is the entity which channels requests for funding and support to projects I + D + i of Spanish companies in the national andinternational levels. The CDTI has a staff of more than 300 people formed three quarters of engineers and graduates. Although the bulk of the infrastructure of the CDTI is located in Madrid, the Centre offers Spanish companies a strategic network of offices and representatives abroad (Japan -SBTO (Spain Business and Technology Office) - Belgium -SOST (Spain Office of Science and Technology) and Permanent Secretariat Eureka-, Brazil -FINEP (Financier of Studies and Projects) -, Korea, Chile, Morocco, China, India, Mexico and USA) to support them in their technological activities of type int .
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Grant, Seed
- Geography: Spain, United States, France
Investor stats
- Total investments: 198
- Round size: Seed $562k–$5.9M; Grant $157k–$16M
- Lead/follow: 40% lead, 60% follow
Portfolio highlights
- Xoople — Xoople operates as an earth intelligence company. Xoople powers the next generation of Earth data intelligence to achieve a systematic understanding of physical changes on the Earth’s surface.
- Orga AI — Organ AI creates generative artificial intelligence that will help people. Its headquarters is located in Palma De Mallorca, Islas Baleares, Spain.
- Golden Owl —
Inveready is a leading Spanish financial services firm focused on investment solutions and wealth management.
Show more...Investment focus
- Industry: Software, Biotechnology, Information Technology
- Stage:Seed, Series A
- Geography: Spain, United States, United Kingdom
Investor stats
- Total investments: 176
- Round size: Seed $400k–$5.5M; Series A $1.6M–$14M
- Lead/follow: 48% lead, 52% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- Qrem —
- Shapelets — Shapelets optimizes GenAI and data visualization with advanced vector databases and agile tools for data professionals
- Wagmi Venture Studio — Wagmi VS is creating transformative web3 experiences that democratize opportunity and ownership of the internet.
Criteria Venture Tech is the tech VC fund of CriteriaCaixa which invests in B2B SaaS and DeepTech companies in early and growth stages (Seed to Series B) managing more than €300M of AUM.
Show more...Investment focus
- Industry: Software, Biotechnology, E-Commerce
- Stage:Seed, Series A
- Geography: Spain, United States, United Kingdom
Investor stats
- Total investments: 151
- Round size: Seed $256k–$3.8M; Series A $1.9M–$21M
- Lead/follow: 40% lead, 60% follow
- Last fund: Likely still investing — fund raised in 2021
Portfolio highlights
- Barbara — Barbara is the Cybersecure Industrial Edge Platform that enables companies to connect, deploy and scale gateways and edge applications in a few clicks
- Minoryx Therapeutics — Minoryx is focused on the discovery and development of novel treatments for severe, orphan diseases of the central nervous system with high unmet medical need.
- iPronics — iPronics develops the innovative concepts of general-purpose integrated programmable photonic systems.
SODENA is the main instrument of the Government of Navarre for the business development of the region. SODENA carries out its activities as a public limited company, with a majority direct shareholding of 65.42% by the Government of Navarre, and an indirect participation through Nafinco (14.58%). It also participates in the shareholding of GrupoCorporativo Empresarial Caja Navarra (20%), through TME 2001 CorpCan, S.L.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Manufacturing
- Stage:Debt Financing, Seed
- Geography: Spain, United Kingdom
Investor stats
- Total investments: 88
- Round size: Seed $110k–$922k; Debt Financing $37k–$743k
- Lead/follow: 31% lead, 69% follow
Portfolio highlights
- DARWIN Biomed — Biomedical Engineering
- Opportunity Health — Self-Applicable & Life-Saving | Fast, safe, and effective in emergencies | Contact us! | Opportunity Health
- El Caserío de Tafalla — El Caserío de Tafalla is a food production company that processes and supplies a variety of candies.
Clave is an investment management company.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Spain, Chile, Switzerland
Investor stats
- Total investments: 42
- Round size: Seed $462k–$5.5M; Series A $3.2M–$16M; Venture - Series Unknown $541k–$7.1M
- Lead/follow: 43% lead, 57% follow
- Last fund: Likely still investing — raised $53M in 2023
Portfolio highlights
- D-Sight — D-Sight is an early treatment for the leading cause of preventable blindness in the working-age population.
- Pharmacelera — Improving pharmaceutical R+D productivity through a lean drug discovery process based on advanced computational methodologies.
- BQC Redox Technologies — Assay kits and devices for rapid and easy quantification of REDOX parameters or biomarkers
Invivo Capital is a team of knowledgeable professionals with the scientific, technical, and financial know-how required to analyze and make investments that provide value to the invested company. They also have a network of contacts and key strategic relationships in the health ecosystem.
Show more...Investment focus
- Industry: Biotechnology, Pharmaceutical, Health Care
- Stage:Seed, Series A
- Geography: Spain, France, Belgium
Investor stats
- Total investments: 26
- Round size: Seed $1.6M–$13M; Series A $2.2M–$70M
- Lead/follow: 35% lead, 65% follow
- Last fund: May invest from a new fund soon — raised $44M in 2019
Portfolio highlights
- ARTHEx Biotech — ARTHEx Biotech S.L. is a spin-off company of the University of Valencia that is developing advanced RNA treatments against genetic diseases.
- Gyala Therapeutics — Gyala Therapeutics is focused on developing new CAR-T therapies for treating hematological malignancies. CAR-T (chimeric antigen receptor T cells) is a type of gene therapy in which T lymphocytes -a type of white blood cells that play a key role in immune responses- are extracted from the patient and modified to attack tumour cells. T lymphocytesare obtained through apheresis (a technique that allows separation of blood components) and genetically reprogrammed with a receptor that binds to a tumor factor. When these cells are transduced back to the patient, they are to specifically recognize tumour cells and attack them. Several types of CAR-T cells have demonstrated efficacy in the treatment of leukemias and B cell lymphomas.
- Telomere Therapeutics — Telomere Therapeutics is a University of Barcelona spinoff developing telomerase gene therapy to treat pulmonary fibrosis
ENISA is a public company under the Ministry of Industry, Energy and Tourism, through the Directorate General of Industry and Small and medium-sized enterprises which, since 1982, actively participates in the financing of viable and innovative business projects.
Show more...Investment focus
- Industry: Software, Health Care, Artificial Intelligence
- Stage:Seed, Debt Financing, Pre-Seed
- Geography: Spain, United States, France
Investor stats
- Total investments: 219
- Round size: Seed $76k–$2.1M; Pre-Seed $188k–$1.2M; Debt Financing $66k–$549k
- Lead/follow: 43% lead, 57% follow
Portfolio highlights
- Naturr — Nature, which seeks to connect small-scale artisanal food producers from rural areas with urban consumers. Nature platform could serve as an important bridge for promoting local and sustainable food systems, benefiting both rural producers and urban consumers i
- Biotasmart —
- DARWIN Biomed — Biomedical Engineering
Asabys Partners is a venture capital firm that invests across the board in human healthcare. The company is active in the health-tech and biopharma industries and aims to invest in Spain and abroad in innovative and transformative technologies. Asabys Partners are motivated by the idea of pushing the boundaries of science and medicine. This is donethrough the sourcing and financing of the most disruptive technologies, and through the collaboration with the best internal and external talents of our industry.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Series A, Series B, Seed
- Geography: Spain, France, Belgium
Investor stats
- Total investments: 38
- Round size: Seed $1.2M–$13M; Series A $7M–$55M; Series B $18M–$135M
- Lead/follow: 50% lead, 50% follow
- Last fund: Likely still investing — raised $117M in 2022
Portfolio highlights
- Orikine Bio — Orikine Bio is a pioneer biotech company in the field of tailored cytokines with unmatched biological properties for the treatment of immune-mediated disorders.
- Splice Bio — Splice Bio is a gene therapy company based on technology developed in the Muir Lab at Princeton University. The company is developing novel gene therapies based on its proprietary intein platform technology to treat patients that suffer from incurable genetic diseases. The company’s platform has the potential to address two existing limitations ofadeno-associated viruses (AAVs), both by increasing the size of the cargo gene that can be delivered and by expanding the range of tissues that can be targeted.
- Ona Therapeutics — Ona Therapeutics is a biotech company that specializes in the discovery and development of therapeutic biologics targeting tumor metastatic-initiating cells and lipid metabolism. Founded in 2019 by Salvador Aznar-Benitah and Valerie Vanhooren, it was a spin-off from ICREA and Advanced Studies, and the IRB Institute for Research in Biomedicine.
CDTI Innovación's INNVIERTE program is part of the Spanish Science, Technology, and Innovation Strategy. This Strategy is one of the cornerstones around which the Government's R&D&I strategy for the upcoming years is built. It outlines the goals, changes, and actions that must be implemented across the R&D&I sector inorder to maximize its growth and effect.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Venture - Series Unknown, Seed
- Geography: Spain, Panama, Switzerland
Investor stats
- Total investments: 50
- Round size: Seed $266k–$6.4M; Venture - Series Unknown $330k–$16M
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- MOA — MOA make healthy food for a sustainable world that solves growing global food demands. They are establishing a new industry of sustainable food that solves growing global food demands without the need for arable land. They are focused on designing high-value, natural and nutritious food.
- Zoundream — The Future of Infant Care
- Ona Therapeutics — Ona Therapeutics is a biotech company that specializes in the discovery and development of therapeutic biologics targeting tumor metastatic-initiating cells and lipid metabolism. Founded in 2019 by Salvador Aznar-Benitah and Valerie Vanhooren, it was a spin-off from ICREA and Advanced Studies, and the IRB Institute for Research in Biomedicine.
Leading #lifesciences #venturecapital firm financing highly #innovative #biotechnology companies #worlwide.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: Spain, United States, Switzerland
Investor stats
- Total investments: 81
- Round size: Series A $3.8M–$61M; Series B $20M–$135M; Series C $27M–$80M
- Lead/follow: 30% lead, 70% follow
Portfolio highlights
- AM Pharma — AM-Pharma B.V., a biopharmaceutical company, engages in the development and commercialization of therapeutics for human use in the Netherlands. It focuses in the pre-clinical and clinical development of novel therapeutics to treat inflammatory and infectious diseases. The company develops products based on endogenous proteins and protein derivedpeptides, as well as molecules that naturally occur in the human body. Its products include alkaline phosphatase for treatment of acute kidney injury and ulcerative colitis; and immune response amplifying peptide hLF1-11 for the treatment of drug resistant hospital acquired infections. The company was founded in 2000 and is headquartered in Bunnik, the Netherlands.
- Splice Bio — Splice Bio is a gene therapy company based on technology developed in the Muir Lab at Princeton University. The company is developing novel gene therapies based on its proprietary intein platform technology to treat patients that suffer from incurable genetic diseases. The company’s platform has the potential to address two existing limitations ofadeno-associated viruses (AAVs), both by increasing the size of the cargo gene that can be delivered and by expanding the range of tissues that can be targeted.
- Synendos Therapeutics — Synendos Therapeutics is a biopharmaceutical company that aims to develop breakthrough safe and effective therapies for unmet needs in neuropsychiatric disorders through modulation of a new drug target in the endocannabinoid system that enables restoration of natural functioning of the brain.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Capital Cell is a crowdinvesting platform for biotech and life sciences companies. Mixing VC, business angels, accredited investors, and the power of the crowd, the company is building a global meeting point for companies and researchers working, fostering, and financing tomorrow’s medical science.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Equity Crowdfunding, Seed
- Geography: Spain, France, United States
Investor stats
- Total investments: 51
- Round size: Seed $384k–$1.9M; Equity Crowdfunding $137k–$1.3M
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- DYNAMICS VR — Dynamics VR provides rehab software for clinics to tackle musculoskeletal pain and movement impairments caused by brain trauma.
- Axoltis Pharma — Axoltis Pharma is a biotech company that develops drugs for degenerative and traumatic neurological disorders.
- EVis Bioscience — EVis Bioscience offers gene delivery solutions using extracellular vesicles, lipid nanoparticles, and hybrid systems.
BeAble Capital is a Science Equity Fund, therefore it is a pre-seed, seed and early stage venture capital management company specialized in the identification, valuation, launch and development of technologies in the sectors of advanced materials (nanotechnology and biotechnology), photonics, micro and nano electronics and Information andcommunications technologies (ICT) platforms.It acts as the link between scientific, entrepreneurial and investing worlds to promote the transfer of technology, the creation and the development of technology-based companies (start-ups) from private equity. The company is focused on strong intelectual property and long R&D background projects. Their work provide value at different stages of development by offering support in strategic points such as the identification of technologies, valuation, transfer, companies creation, fundraising, marketing, internationalization and administrative and managerial expertise.
Show more...Investment focus
- Industry: Biotechnology, Manufacturing, Software
- Stage:Pre-Seed, Seed
- Geography: Spain, Italy
Investor stats
- Total investments: 69
- Round size: Seed $154k–$1.2M; Pre-Seed $124k–$274k
- Lead/follow: 83% lead, 17% follow
- Last fund: May invest from a new fund soon — raised $37M in 2016
Portfolio highlights
- Molecular Gate — Molecular Gate refer to an innovative class of small-molecule drugs developed by Gate Bioscience. These drugs target the secretory translocon (Sec61 channel) in cells to selectively block and degrade harmful extracellular proteins before they can be secreted and cause disease.
- Bioinspired Materials — Bioinspired Materials is a Biotech-based entrepreneurship project with the participation of the Universitat Pompeu Fabra. The company develops wastewater valorization that produces biological products of high value in the market. BIOM was founded in 2019 and is based in Barcelona, Spain.
- Ars Magna Semiconductors — Ars Magna Semiconductors develops semiconductor chips designed for decentralized artificial intelligence applications. The company's technology operates with low energy consumption, real-time processing, and enhanced data privacy by reducing the number of operations and hardware requirements. Their chips address the global semiconductorshortage while enabling more efficient AI processing with reduced computational overhead.
Alta Life Sciences is a leading multistage venture capital investment firm. Alta LS will invest in companies at all stages of development: from seed financing through commercial growth. Alta LS invests in all areas of life sciences including biotechnology, medical devices, diagnostics, genomics and digital health.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical Device
- Stage:Series A, Series B
- Geography: Spain, United States
Investor stats
- Total investments: 18
- Round size: Series A $3M–$33M; Series B $14M–$87M
- Lead/follow: 44% lead, 56% follow
Portfolio highlights
- DeepUll — DeepUll is a biotech company that focuses its activity on the development of a new diagnostic system for early-stage sepsis condition. DeepUll’s proposal is based on quickly identifying the pathogens and offering the antibiogram within a few hours on the one hand, and on using the data and learning about the patient’s immunological and functionalstatus on the other. The system allows doctors to predict the future appearance and evolution of sepsis within a short period of time and thus provide a suitable clinical response even before the symptoms arise.
- Peptomyc — Peptomyc is a company focused on the development of a new generation of cell-penetrating peptides (CPPs) targeting the Myc oncoprotein for cancer treatment. The company was founded in December 2014 and it is based on Dr. Soucek’s scientific research in Omomyc (the best direct Myc inhibitor known to date) over the last twenty years.Currently,cancer incidence in the world exceeds 14 million cases per year and results in 8 million deaths annually. Moreover, such numbers are forecast to rise by 75% over the next 20 years (World Cancer Report. International Agency for Research on Cancer 2014). At the moment, standard therapies include surgery, radiotherapy, chemotherapy, and, in a restricted subset of cancers, precision medicine. Unfortunately, very often these therapies fail, due to the development of resistance.Peptomyc has adopted a different strategy based on the inhibition of the oncoprotein Myc, which is found deregulated in the majority of human cancers. Myc holds a non-redundant function in cancer around which tumors cannot evolve, hence targeting Myc is the most promising therapeutic opportunity to date. Although Myc plays a central role in cancer there is currently no Myc inhibitor in the market.
- Ona Therapeutics — Ona Therapeutics is a biotech company that specializes in the discovery and development of therapeutic biologics targeting tumor metastatic-initiating cells and lipid metabolism. Founded in 2019 by Salvador Aznar-Benitah and Valerie Vanhooren, it was a spin-off from ICREA and Advanced Studies, and the IRB Institute for Research in Biomedicine.
ICF Capital is a venture and growth capital management firm from ICF. ICF is a public financial institution founded in 1985 and owned by the Government of Catalonia. Our mission is to foster and improve access to funding for companies that operate in Catalonia in order to contribute to the growth of the region's economy while complementing theprivate financial sector. ICF provides funding to Catalan companies and entrepreneurs. They assist them in their development and growth, generating value for society at large. The institution offers companies a range of products and services in the area of corporate finance, focusing on loans and guarantees and venture capital investments. ICF operates via a parent company, two subsidiaries (IFEM and ICF Capital), and an investee (AVALIS). ICF, through IFEM, supports the creation and growth of innovative start-ups through the investment in venture capital funds for seed segments and co-investment with private investors through participative loans. ICF Capital, which manages closed-end UCITS and is authorized by Spain's National Securities Market Commission (CNMV), manages, nurtures, and advises public and/or private funds or venture capital firms that provide capital to Catalan companies. At present, ICF Capital directly manages 2 venture capital firms: ICF Capital Expansió II and ICF Venture Tech II.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Debt Financing, Seed
- Geography: Spain, United States, Mexico
Investor stats
- Total investments: 110
- Round size: Seed $1.1M–$6.9M; Debt Financing $110k–$549k
- Lead/follow: 20% lead, 80% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- Salicru — Salicru offers energy optimization and protection of technological equipment that causes incidences in the electrical supply.
- BRICKBRO — Currently, Brickbro is one of the leading real estate transactional platforms in the spanish market.
- ATTSU — ATTSU is a machinery manufacturing company that offers steam boilers and thermal oil boilers for industrial purposes.
Independent Venture Capital Firm specialized in high technology Spanish start-ups. Helping tech entrepreneurs during the early stages of their company to build successful businesses
Show more...Investment focus
- Industry: Software, Information Technology, Manufacturing
- Stage:Seed, Series A
- Geography: Spain, United States, Mexico
Investor stats
- Total investments: 64
- Round size: Seed $1M–$3.3M; Series A $587k–$11M
- Lead/follow: 42% lead, 58% follow
- Last fund: Likely still investing — raised $47M in 2023
Portfolio highlights
- FlexiiC — FlexiiC is a deep-tech firm developing printed, flexible integrated circuits for sustainable IoT and smart packaging solutions.
- Bioherent — Photonic biosensors for drug allergy diagnosis
- Impetux Optics — IMPETUX develops and markets patented technology to characterise the mechanical properties of living tissues and cells. We are focusing the application of our technology in fields like Mechanobiology where the study of diseases directly related with cell migration or development are demanding new techniques. We offer cutting-edge non-invasive to...
CRB Inverbio is a private venture capital management firm specialized in life sciences investing in innovative early stage start- ups in biotech, med tech, digital health and medical technologies
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Series A, Seed
- Geography: Spain, Italy, Mexico
Investor stats
- Total investments: 14
- Round size: Seed $3.3M–$5.3M; Series A $2.2M–$8.9M
- Lead/follow: 36% lead, 64% follow
- Last fund: May invest from a new fund soon — raised $70M in 2010
Portfolio highlights
- Nuubo — Nuubo is a Spanish medical device company that develops wireless, wearable technologies to monitor physiological parameters. To do so, Nuubo has a platform known as nECG DYNAMIC PLATFORM, which makes it easier to perform and read an electrocardiogram remotely. Specifically, the system patented by Nuubo is made up of three elements: a biomedicalgarment that allows the electrocardiogram signal to be captured without interfering with the patient’s daily activity; a device that continuously records the information captured by the garment and which also allows the data to be sent wirelessly and in real time for processing; and analysis and visualization software that, using artificial intelligence algorithms, can interpret all of the information transmitted by the wireless device.The devices designed by Nuubo allow patients’ hearts to be monitored for longer periods of time and without feeling uncomfortable or intrusive. The company is headquartered in Madrid, Spain.
- Prosoma — Prosoma was born out a need to provide more comprehensive care for cancer patients. We have found a fundamental lack of access to psychological care for patients who not only have to face a life-altering disease and treatment, but also crucially have a different set of needs than other psychological patients. Barriers to accessing psychologicalcare often include low numbers of therapists and clinicians in the area, financial or geographical limitations, and the general wellbeing of patients preventing them from attending meetings. All of these issues can be solved by modern technology.By using VR as part of, or when necessary, an alternative to traditional psychological treatment, we can reach patients that would otherwise be left without any support. They can use our tool at home or in the clinics whilst undergoing pharmacological treatment and chemotherapy.We hope to provide patients with a tool that will help them manage stress, cope with the burden of cancer, and eventually improve their quality of life.
- Carol — Carol is a tech-enabled healthcare provider delivering membership-based primary care services, on a mission to make high-quality healthcare accessible and affordable for everyone. To achieve this goal, Carol leverages a highly scalable technology, combined with high quality clinical operations and a salaried provider model.
XesGalicia is a Galician Venture Capital Management firm. It finances company development through the temporary acquisition of minority shares of the capital of unquoted companies.
Show more...Investment focus
- Industry: Software, Biotechnology, Pharmaceutical
- Stage:Seed, Pre-Seed
- Geography: Spain, Portugal
Investor stats
- Total investments: 33
- Round size: Seed $304k–$5.9M; Pre-Seed $439k–$2.5M
- Lead/follow: 15% lead, 85% follow
Portfolio highlights
- Kreios Space — Kreios Space is developing an electric propulsion system to revolutionize the satellite industry. With this technology we enable orbital keeping in VLEO (Very Low Earth Orbits) thanks to renewable energy. We make space applications easier.
- VigSec-Drone — VigSec-Drone is a high-performance security and surveillance designed to deliver real-time situational awareness.
- Iteria Biopharma — Iteria Biopharma focused on discovering and developing precision oncology drugs, particularly first-in-class new chemical entities (NCEs) for challenging cancer targets with high unmet medical needs.
AdBio partners is a European Life Sciences Venture Capital firm dedicated to seeding healthcare’s step forward.We work with leading research institutions and well-established technology transfer offices, with a strong network of scientific and medical partners, exploring new territories to source breakthrough medical discoveries and driveinventive Life Sciences start-ups to success.We embrace European Life Sciences’ dynamic of innovation. Europe harbors a vibrant environment for medical and scientific investigation, with some of the most leading-edge academic and research centers. AdBio partners seizes the opportunity to highlight their undervalued research programs and assets and participate in structuring Europe’s biotechnology ecosystem.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Seed, Series A
- Geography: France, Spain, Belgium
Investor stats
- Total investments: 32
- Round size: Seed $2.2M–$18M; Series A $18M–$37M
- Lead/follow: 41% lead, 59% follow
- Last fund: Likely still investing — raised $116M in 2021
Portfolio highlights
- Orikine Bio — Orikine Bio is a pioneer biotech company in the field of tailored cytokines with unmatched biological properties for the treatment of immune-mediated disorders.
- ARTHEx Biotech — ARTHEx Biotech S.L. is a spin-off company of the University of Valencia that is developing advanced RNA treatments against genetic diseases.
- Integra Therapeutics — Integra Therapeutics is a developer of next generation of gene editing tools to cure diseases.
SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Convertible Note, Pre-Seed
- Geography: United States, India, United Kingdom
Investor stats
- Total investments: 1482
- Lead/follow: no public data
Portfolio highlights
- MixRift — MIXRIFT - game developers specialized in Mixed Reality
- unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
- Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
A Banc Sabadell initiative to support young companies in developing their projects. Bstartup is designed to support entrepreneurs so their projects can be developed with maximum guarantees of success. - Investment and growth - Specialized products and branches - Collaborative innovation
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Pre-Seed
- Geography: Spain, Mexico, United States
Investor stats
- Total investments: 82
- Round size: Seed $110k–$2.2M; Pre-Seed $219k–$900k
- Lead/follow: 45% lead, 55% follow
Portfolio highlights
- TietAI — TietAI builds healthcare data interoperability infrastructure for hospitals, research networks and life sciences. The platform, Hydra, is split into two products. Hydra Connects is non-medical-device middleware for clinical data exchange across HL7v2, FHIR, DICOM, OMOP, X12 and CDA. Hydra Agentic is a high-risk AI system under the EU AI Act,designed for clinical agentic workflows.
- Energiot — Energiot specialized engineering service in energy harvesting, self-powered devices, wireless sensor networks.
- Floatech — Discover Floatech: Boosting lithium-ion batteries with sustainable, high-performance silicon anodes. Explore our innovative technology.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Venture Capital for Entrepreneurs with seasoned experts and advisors to succed in creating value in a meaningful way. Coaching and Mentoring Ideas People
Show more...Investment focus
- Industry: Health Care, Biotechnology, Artificial Intelligence
- Stage:Seed, Pre-Seed, Venture - Series Unknown
- Geography: Spain
Investor stats
- Total investments: 25
- Round size: Seed $549k–$9.5M; Pre-Seed $106k–$2.5M; Venture - Series Unknown $218k–$794k
- Lead/follow: 56% lead, 44% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- Tirecat — Tirecat specialized in developing sophisticated tissue regeneration treatments to combat chronic and terminal diseases.
- NSS Water —
- The Blue Box Biomedical Solutions — Pain-free, low-cost, sensitive, radiation-free device to detect breast cancer in urine
Gestión de Capital Riesgo del PaÃs Vasco SGECR, S.A. is a venture capital entity management company founded in 1985 by the Basque Government as part of the Sociedad para la Promoción y Reconversión Industrial (SPRI), with the aim of promoting and developing venture capital activity in the Basque Country.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Series A
- Geography: Spain, Ecuador
Investor stats
- Total investments: 23
- Round size: Seed $213k–$2.3M; Series A $329k–$14M
- Lead/follow: 35% lead, 65% follow
- Last fund: May invest from a new fund soon — last raise in 2014
Portfolio highlights
- InspectRail — InspectRail was established to offer high-quality information on the state of railway infrastructure, thereby enhancing its operation, management, and maintenance.
- Orbik Cybersecurity — Orbik Cybersecurity provides testing and compliance services for industrial equipment and embedded electronics.
- Inmedical Therapeutics — Innovative medical devices designed to meet real clinical needs, combining science, know-how and therapeutic research.
Moira Capital Partners is private equity firm
Show more...Investment focus
- Industry: Biotechnology, Apps, Water Purification
- Stage:Private Equity, Venture - Series Unknown
- Geography: Spain
Investor stats
- Total investments: 17
- Round size: Private Equity $7.9M–$18M; Venture - Series Unknown $5.5M–$15M
- Lead/follow: 82% lead, 18% follow
Portfolio highlights
- Cubiq Foods — Cubiq Foods has developed a platform of cultivate fats for industrial clients. It is based on two main ingredients, Cubiq Smart OMEGA-3 and Cubiq Smart Fat
- Xcalibur — Your Strategic Ally in Sustainable Energy Transition. Airborne Survey Solutions for Comprehensive Resource Mapping
- Geodesic Innovations — Geodesic Innovations is a water-saving and purification company that develops advanced water treatment, conservation, and regeneration systems to offer services for disinfection and improvement of water quality without using chemicals.
Amadeus Capital Partners, Venture Capital For Technology Companies. We Back Entreprenuers To Win. Contact Our Experienced Team Of Investors Today
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Series B, Series A
- Geography: United Kingdom, United States, Spain
Investor stats
- Total investments: 237
- Round size: Seed $900k–$9.2M; Series A $2.6M–$30M; Series B $6.8M–$43M
- Lead/follow: 29% lead, 71% follow
- Last fund: Likely still investing — raised $88M in 2023
Portfolio highlights
- Tenzo — Tenzo is a restaurant analytics and AI forecasting platform for restaurants, pubs and cafes. Tenzo makes running restaurants easy with full data visibility.
- Slamcore — Positioning, mapping and perception | State-of-the-art visual SLAM turns sensor data into actionable, spatial understanding for your vehicles.
- Unifyr — IDC MarketScape Leader 2025. AI-native PRM platform for partner onboarding, enablement, deal registration, and through-channel marketing.
Angels Capital philosophy is to find and support at 1 able to lead a project. Their goal is to support the entrepreneurial, helping to create new businesses, help grow their business sector, generate employment and create wealth.
Show more...Investment focus
- Industry: Software, E-Commerce, Health Care
- Stage:Seed, Angel, Pre-Seed
- Geography: Spain, United States, Ireland
Investor stats
- Total investments: 127
- Round size: Seed $212k–$2.5M; Angel $104k–$1.6M; Pre-Seed $323k–$994k
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- Citring — Citring is a smart juicer to make orange juice automatically.
- Trak — Trak is a software tool for healthcare professional to provide AI-based tele-rehabilitation services like physiotherapy and others.
- Biotasmart —
Clave Mayor is a management company of closed investment entities based in Navarra.
Show more...Investment focus
- Industry: Software, Biotechnology, Medical
- Stage:Seed, Series A
- Geography: Spain, Germany, United States
Investor stats
- Total investments: 33
- Round size: Seed $262k–$5.5M; Series A $2.2M–$8.9M
- Lead/follow: 21% lead, 79% follow
Portfolio highlights
- MOA — MOA make healthy food for a sustainable world that solves growing global food demands. They are establishing a new industry of sustainable food that solves growing global food demands without the need for arable land. They are focused on designing high-value, natural and nutritious food.
- Ojer Pharma — Ojer Pharma engages in the research, development, production, and marketing of dermopharmaceutical products in Spain. It develops prescription medicines, cosmetics, and medical devices. The company has developed a vehiculization technology in the form of bioadhesive transparent gels, which acts as a sustained-release matrix of dermatologicalactives, such as lipophilics and hydrophilics.
- Semi Zabala — Welcome to Semi Zabala, a pioneering semiconductor company dedicated to innovation and excellence. Our mission is to push boundaries and enhance technology, embodying our slogan: beyond the power. Explore our advanced solutions designed for a smarter, more connected future.
Developing combustion engine catalyst and coating technology to reduce emissions and improve fuel efficiency for clean energy production.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Debt Financing
- Geography: Spain, United States, Mexico
Investor stats
- Total investments: 34
- Round size: Seed $285k–$2.6M; Debt Financing $274k–$472k
- Lead/follow: 12% lead, 88% follow
Portfolio highlights
- PLD Space — PLD Space is a spanish innovative start-up company is to provide low cost and high reliability access to space. PLD Space offers suborbital and orbital launch services to its clients.
- SummuS Render — SummuS is a render farm, who offers 3D rendering and massive computing capabilites as a service. Companies demanding massive calculations for short periods of time can hire either the infraestructure or they can pay a price per Ghz per hour. This service allows them to avoid huge costs in hardware, personnel and system maintenance.
- Atlas Molecular Pharma — Latest News Your browser does not support the video tag.
Columbus Venture Partners is Spanish independent venture capital. It focuses on investing in early-stage opportunities in the life science industry. The firm is a team of investment professionals with a scientific, medical, and business development background combined with experience in building and investing in companies to accelerate theircommercialization.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Seed
- Geography: Spain, United States, United Kingdom
Investor stats
- Total investments: 26
- Round size: Seed $1.7M–$20M; Series B $26M–$87M
- Lead/follow: 58% lead, 42% follow
- Last fund: May invest from a new fund soon — raised $127M in 2021
Portfolio highlights
- Artax Biopharma — Discover Artax Biopharma's pioneering Nck modulators that restore immune balance without immunosuppression. Learn more about our clinical advancements.
- Ona Therapeutics — Ona Therapeutics is a biotech company that specializes in the discovery and development of therapeutic biologics targeting tumor metastatic-initiating cells and lipid metabolism. Founded in 2019 by Salvador Aznar-Benitah and Valerie Vanhooren, it was a spin-off from ICREA and Advanced Studies, and the IRB Institute for Research in Biomedicine.
- Integra Therapeutics — Integra Therapeutics is a developer of next generation of gene editing tools to cure diseases.
Seed Capital de Bizkaia is a Regional Council company affiliated to Biscay Regional Council's Department of Economic Development and Innovation (Departamento de Innovación y Promoción Económica de la Diputación Foral de Bizkaia) whose aim is to manage a Venture Capital Fund called “Seed Capital Bizkaia, F.C.R.“.
Show more...Investment focus
- Industry: Software, Biotechnology, Health Care
- Stage:Seed, Series A
- Geography: Spain, Mexico, Belgium
Investor stats
- Total investments: 34
- Round size: Seed $119k–$2.9M; Series A $2.7M–$14M
- Lead/follow: 26% lead, 74% follow
Portfolio highlights
- NNEAT — NNEAT operationalizes Continuous Threat Exposure Management (CTEM) and powers MITRE ATT&CK®-aligned Threat-Informed Defense (TID).
- Emica Solar — Emica Solar is a company which develops the floating solar energy.
- Revenant Industrial & Ports Machinery — Revenant returning to the revolution in internal logistics, container manipulators, and the remanufacturing of large tonelaje carretillas.
As asset managers, we invest on behalf of third parties. Our fear of losing their money is greater than the fear of losing an opportunity. Our investment style consists of value orientation, specialization and trust, applying our investment criteria in a disciplined way. We invest to transform the companies into industry leaders. With a hands-onapproach, Nara invests in assets enhancing its value with a long-term view. We are a highly experienced team with the patience and tenacity required to see deals through, committing our own money. We create value in a sustainable way, investing in a responsible way to generate a positive impact on the community. We analyze each investment in detail in order to create shared value for our investors, partners, customers, suppliers and workers.
Show more...Investment focus
- Industry: Life Science, Biotechnology, Medical
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: Spain
Investor stats
- Total investments: 10
- Round size: Seed $394k–$7.3M; Venture - Series Unknown $1.9M–$3.3M
- Lead/follow: 30% lead, 70% follow
Portfolio highlights
- Aortyx — With a focus on aortic dissection, Aortyx has developed a bioresorbable endovascular patch designed to seal the entry tear, delivered through a proprietary dual-steerable catheter.
- MiMARK — MiMARK focuses on improving the accuracy and efficiency of diagnostics for endometrial cancer, which is the sixth most commonly occurring cancer in women.1 As with many cancers, early and accurate detection of the disease is linked to increased survival, however currently around a third of endometrial cancer patients are diagnosed at the advancedstage.2 By improving the technology available for the diagnosis of endometrial cancer, MiMARK hopes to improve the speed and accuracy at which women can be diagnosed and effectively treated.
- Neboda — We are an indoor vertical farming company that combines combines a scientific approach and an industrial automation background.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!WA4STEAM is an all women angels investment group delivering worldwide access to seed capital for women entrepreneurs led startups in STEAM Science, Technology, Engineering , Architecture & Architecture and Mathematics
Show more...Investment focus
- Industry: Health Care, Biotechnology, Artificial Intelligence
- Stage:Seed, Pre-Seed, Series A
- Geography: Spain
Investor stats
- Total investments: 21
- Round size: Seed $392k–$4.2M; Pre-Seed $713k–$1.2M
- Lead/follow: 24% lead, 76% follow
Portfolio highlights
- Break-Event — Break-Event aids music industry professionals and businesses by transforming information into knowledge. They are dedicated to providing the product, enabling customers to make wiser decisions, and ensuring the performance of events.
- Hair Up Laser — Making alopecia a problem of the past.
- Genbioma — Genbioma is a biotechnology company transforming microbiome science into clinically validated postbiotics that support metabolic health, improve glucose control, and naturally activate the GLP-1 pathway.
Cofides provides cost-effective, medium and long-term financial support for viable private investment projects.
Show more...Investment focus
- Industry: Manufacturing, Health Care, Industrial
- Stage:Debt Financing, Private Equity, Series B
- Geography: Spain, Ecuador
Investor stats
- Total investments: 48
- Round size: Series B $42M–$87M; Debt Financing $219k–$24M; Private Equity $6.1M–$105M
- Lead/follow: 94% lead, 6% follow
Portfolio highlights
- Bike Ocasion — Bike Occasion offers certified bicycles, a one-year warranty, and home delivery of bikes. It also provides bicycle repair services. In addition to prioritizing sports and cycling, the firm strives to preserve the environment without compromising on its values.
- Thermogreen — Thermogreen manufactures and markets extruded polystyrene (XPS) for use in thermal insulation, which helps to sustainable and energy-efficient building while ensuring the well-being and comfort of its occupants.
- Fersa Bearings S.A. — Fersa Bearings is a Spanish multinational dedicated to the design, development, manufacture and distribution of complete solutions of high quality bearings for the automotive market. It has more than 50 years of experience in the sector and, since 2016, it forms part of the Fersa Group business group together with the Austrian manufacturer ofindustrial bearings, NKE.
Fitalent (FIT Investment Talent SCR Simplified Regime SL) is a venture capital firm formed in early 2011 and registered in the special register of the National Securities Market Commission (CNMV), which invests in technology companies and proven successful products , whose main asset are people and talent .Their mission is to assistentrepreneurs to get consolidated, profitable and leading companies in the technology market segment. They want to be financial and strategic partners of the companies in which they participate.
Show more...Investment focus
- Industry: Biotechnology, Analytics, Health Care
- Stage:Seed, Series A
- Geography: Spain
Investor stats
- Total investments: 15
- Round size: Seed $165k–$2.6M; Series A $329k–$4.8M
- Lead/follow: 47% lead, 53% follow
Portfolio highlights
- Citibeats — Citibeats uses AI and cutting-edge technology to transform ethically sourced public opinions into real-time, data-driven actionable insights. Monitor trends surrounding sustainability, social risk, and more.
- Oncostellae — Oncostellae is a biotechnology startup developing small-molecule drugs with innovative scaffolds (NCEs) that modulate clinically validated therapeutic targets in oncology and inflammatory/autoimmune diseases.
- Ability Pharmaceuticals — Ability Pharmaceuticals is a drug discovery and development company based in Barcelona, Spain. It develops human therapeutics targeting cell membranes to treat cancer and other indications with unmet medical needs.Ability Pharmaceuticals is focused on developing new drugs for the treatment of lung cancer and pancreatic cancer. The companydevelops Lipid Analogue Therapeutics, a new drug class that modifies the composition of the cell membrane and displays a capacity to influence the local organization of lipid structures in the cell membrane, inducing the formation of non-lamellar phase structures.Its development pipeline includes ABTL0812 product in preclinical development; and ABTL1014, a drug candidate in preclinical characterization.
Pirate Impact is a Family office with focus on stage-agnostic direct investments in climate-tech & social impact companies in the EU & US.
Show more...Investment focus
- Industry: EdTech, E-Learning, Renewable Energy
- Stage:Seed, Series C
- Geography: Germany, Spain, Denmark
Investor stats
- Total investments: 7
- Round size: Seed $4M–$13M
- Lead/follow: 14% lead, 86% follow
Portfolio highlights
- XFuel — XFuel is a fuel company that provides green and clean fuels to distributors and consumers. The company was founded in 2010 and is based in Palma de Mallorca, Baleares.
- Labster — Labster empowers educators to reimagine their science courses with immersive online simulations. Request a demo to discover how Labster engages students, trains lab skills, and accelerates learning.
- Minimum — Take control of your organization's carbon accounting and management with granular, robust and auditable emissions data.
Union Square Ventures is a venture capital firm based in New York City.
Show more...Investment focus
- Industry: Software, Financial Services, FinTech
- Stage:Series A, Series B, Seed
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 431
- Round size: Seed $2M–$13M; Series A $3.3M–$24M; Series B $6M–$40M
- Lead/follow: 45% lead, 55% follow
- Last fund: Likely still investing — raised $200M in 2022
Portfolio highlights
- Tucows — Tucows is a tech company headquartered in Toronto, Canada since 1993. Tucows offers mobile, fiber Internet and domain name services as Ting, Hover, OpenSRS, Enom, Epag and Ascio.
- Tandems — Tandems enhances the way financial advice is delivered by equipping advisors, bankers, and agents with data-driven insights and personalized recommendations. Tandems focuses on improving institutional operations through automation and intelligent decision-support tools that streamline workflows and client engagement. The company’s technology isdesigned to augment human expertise, allowing financial professionals to allocate more time to strategic guidance and relationship building.
- Otis — Otis is a fractional ownership platform that makes it possible for almost anyone to buy and sell shares of collectibles, sneaker grails, rare comics, art, and more. Low minimums. Get started today.
The European Investment Bank (EIB) offers lending, borrowing, and treasury services primarily within the European Union. It provides project loans for public and private sectors, loans to banks and intermediaries, structured finance products, guarantees, and securitization instruments for debts. Additionally, EIB offers equity and fund investmentproducts, including infrastructure and environmental funds, as well as venture capital funds. EIB also supports microfinance and risk-sharing finance for research and innovation, and provides technical expertise for sustainable energy projects. Its services include infrastructure advisory, urban development support, guarantees for transport infrastructure, and funding for public-private partnerships and small- to medium-sized enterprises. The bank serves various sectors, including transportation, energy, health, education, and agriculture.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Energy
- Stage:Debt Financing, Post-IPO Debt
- Geography: France, Germany, The Netherlands
Investor stats
- Total investments: 488
- Round size: Post-IPO Debt $16M–$658M; Debt Financing $16M–$370M
- Lead/follow: 82% lead, 18% follow
Portfolio highlights
- RE:OCEAN — OUR MISSION IS TO FARM SALMON FOR THE BENEFIT OF HEALTH AND THE PLANET. WE'LL DO THIS BY BUILDING A LARGE SCALE FISH FARM IN THE middle OF SWEDEN. - WE'RE MAKING THE IMPOSSIBLE POSSIBLE - AN OCEAN ON LAND. RE:OCEAN IN BRIEF One in five salmons in Sweden 2026 will come from RE:OCEAN Fresh
- Wandercraft — Self- balancing and hands free movement with the innovative self-balancing feature, Atalante allows for multi-tasking and cognitive involvement as part of treatments.
- IPT PowerTech — IPT PowerTech coverage, coupled with our extensive expertise in supply chain management, field implementation, and power systems, has made us one of the most capable companies in handling the most complicated and versatile projects in the MEA region and its neighboring countries.
Faber is a Lisbon-based venture capital firm investing in outstanding entrepreneurs who innovate at the intersection of science and technology to drive digital transformation and climate action. The firm combines a specialist focus on deep tech early-stage startups with dedicated funds, investment teams and expert advisors to actively helpfounders build global companies powered by AI/Data, Web3 or Ocean/Climate technologies.Faber’s unique approach in Southern Europe is led by an entrepreneurial management partnership and backed by notable thesis-driven institutions and private investors. Investing since 2013, the firm has been an early investor in hard tech companies such as Unbabel, SWORD Health, Codacy, iLoF or YData.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, SaaS
- Stage:Seed, Pre-Seed, Series A
- Geography: Portugal, United States, United Kingdom
Investor stats
- Total investments: 91
- Round size: Seed $549k–$5.2M; Pre-Seed $34k–$3.8M; Series A $2.5M–$25M
- Lead/follow: 27% lead, 73% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- Vyoma GmbH — Vyoma ensures satellite safety and real-time mapping of space objects with cameras on satellites paired with automation services.
- Apres — Apres is a distributed learning engine built to enable high-performance, user-friendly AI for the world.
- ATMOS Space Cargo — ATMOS Space Cargo develops and manufactures space capsules to return cargo from space, microgravity experiments, Commercial products to entire rocket stages.
ICF - Institut Català de Finances provides financial services.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Debt Financing, Seed
- Geography: Spain, Germany
Investor stats
- Total investments: 13
- Round size: Seed $2.4M–$2.9M; Debt Financing $1.7M–$44M
- Lead/follow: 69% lead, 31% follow
Portfolio highlights
- D-Sight — D-Sight is an early treatment for the leading cause of preventable blindness in the working-age population.
- Super's Diana — Super’s Diana develops, manufactures, and markets medicines and supplements for swine, cattle, and poultry livestock in over 30 countries.
- Labiana Life Sciences — LABIANA GROUP has unique operational flexibility and a great capacity to offer high quality contract manufacturing services to all companies in the sector, regardless of batch size required.
Startupxplore is a premium startup investment platform that allows unexperienced and time-savvy investors to diversify their portfolio by co-investing with a group of top-level investors with a proven track record on startup investment.
Show more...Investment focus
- Industry: Artificial Intelligence, Health Care, Software
- Stage:Pre-Seed, Seed, Convertible Note
- Geography: Spain
Investor stats
- Total investments: 28
- Round size: Seed $276k–$870k; Pre-Seed $111k–$612k
- Lead/follow: 36% lead, 64% follow
Portfolio highlights
- Heuristik — Heuristik is a software solution that helps healthcare entities identify and manage patients by combining fingerprint recognition and artificial intelligence. They help with process planning and the administrative management of patients through the use of statistical analysis and proprietary management algorithms.
- Biel Glasses — Biel Glasses is a company from Barcelona developing smart glasses to improve the quality of life of people with low vision.
- Opportunity Health — Self-Applicable & Life-Saving | Fast, safe, and effective in emergencies | Contact us! | Opportunity Health
AENU is an evergreen impact fund that focuses on stage-agnostic long-term investments in climate-tech and social impact companies.
Show more...Investment focus
- Industry: Renewable Energy, Software, CleanTech
- Stage:Seed, Series A, Series B
- Geography: Germany, United States, United Kingdom
Investor stats
- Total investments: 64
- Round size: Seed $2.4M–$12M; Series A $8.8M–$53M; Series B $11M–$87M
- Lead/follow: 22% lead, 78% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- Entrix — Entrix is an optimisation and trading platform for grid-scale battery storage that accelerates the transition towards a clean energy future. Our mission is to enable the most effective use of green energy and to ensure the reliability of the future energy system. We provide state-of-the-art technology and services to both asset owners and potentialinvestors across the globe.
- GALVANY — GALVANY is a climate-tech company focused on end-to-end heat pump and energy-management solutions for homes and buildings.
- Plume — Analyze all geospatial, grid, and regulatory constraints simply with natural language. AI-powered site selection for renewable energy and infrastructure projects.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!A privately held asset management company that invests in early-stage life science companies.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Security
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Spain, Switzerland
Investor stats
- Total investments: 6
- Round size: Seed $805k–$2.7M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Bearmind — Bearmind developing technology for monitoring and real-time analysis of head impact in athletes.
- Nanoligent — Explore how Nanoligent uses cutting-edge technology to design precision medicines, enhancing treatment efficacy and patient outcomes.
- Onena Medicines — Onena Medicines is a biotechnology company that creates innovative biological medicines to address the large unmet clinical need for breast cancer and other serious orphan illness.
GED is an independent Private Equity group operating in the Iberian Peninsula and South-Eastern Europe. The company was incorporated in 1996 and GED’s professional Partners hold a majority stake in the Management Companies of the Group.GED is positioned in the middle market, managing funds in excess of €300M through 4 different Private Equityvehicles and operates in two different private equity sectors; private equity and private equity-real estate.GED Private Equity is looking at buyouts and expansion deals maximizing the portfolio value through a clear buy and build strategy in the core countries: Romania, Bulgaria, Spain and Portugal, backing medium size companies that can become regional market leaders.GED Opportunity targets opportunistic and value added real estate investments in South Eastern Europe.GED has a strong track record in Eastern Europe and the Iberian Peninsula, achieved it during its 19 years activity in the region through offices in Madrid, Seville, Bucharest, Sofia and Oporto.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Restaurants
- Stage:Private Equity, Seed, Series A
- Geography: Spain, Ecuador, Romania
Investor stats
- Total investments: 15
- Round size: Seed $2.9M–$4.4M; Series A $8M–$50M
- Lead/follow: 60% lead, 40% follow
- Last fund: May invest from a new fund soon — raised $117M in 2019
Portfolio highlights
- Quibim — Quibim builds AI tools that turn MRI, CT and PET data into actionable predictions for hospitals and biopharma. Trusted in 230+ centers worldwide.
- Xoople — Xoople operates as an earth intelligence company. Xoople powers the next generation of Earth data intelligence to achieve a systematic understanding of physical changes on the Earth’s surface.
- Eranovum — Eranovum manages the development and construction of renewable energy projects in Spain using new era energy infrastructure.
Gus Bertolo
Show more...Investment focus
- Industry: Software, Biotechnology, Artificial Intelligence
- Stage:Seed
- Geography: Spain
Investor stats
- Total investments: 2
- Lead/follow: no public data
Portfolio highlights
- Insectius — Insectius uses artificial intelligence (AI) in insect breeding, management, and manufacture of insect flour.
Alberto Hospital Marco
Show more...Investment focus
- Industry: SaaS, Software, Logistics
- Stage:Seed
- Geography: Spain
Investor stats
- Total investments: 3
- Lead/follow: no public data
Portfolio highlights
- Freightol — Freightol is a technological startup with the mission to digitize the transport and logistics industry. To make this industry more innovative and efficient, we used Freightol Manager, a complete digital platform that digitizes all parts of a Global Freight Forwarder: its logistical operations, handling and management of shipments, quotations,billing and customs, from the beginning to the end in real time.
- Insectius — Insectius uses artificial intelligence (AI) in insect breeding, management, and manufacture of insect flour.
Kurma Partners is a management company based in Paris, specializing in the financing of innovation in healthcare and biotechnology, from pre-creation to development capital. Kurma Partners, which manages the Kurma Biofund I, II funds and the Kurma Diagnostics fund, is one of the main players in the financing of therapeutic and medical innovationsin Europe, particularly through links with many institutes. research and prestigious hospitals.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Seed, Series B
- Geography: France, Switzerland, Spain
Investor stats
- Total investments: 138
- Round size: Seed $2.3M–$17M; Series A $3.8M–$95M; Series B $12M–$72M
- Lead/follow: 47% lead, 53% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- EvlaBio — EvlaBio is a biotech company focused on the development of drug programs that address significant unmet medical needs. The company's pipeline includes robust scientific antibody programs for the treatment of hepatocellular carcinoma (Phase 1 ready) and chronic kidney disease with left ventricular hypertrophy (pre-clinical).
- AM Pharma — AM-Pharma B.V., a biopharmaceutical company, engages in the development and commercialization of therapeutics for human use in the Netherlands. It focuses in the pre-clinical and clinical development of novel therapeutics to treat inflammatory and infectious diseases. The company develops products based on endogenous proteins and protein derivedpeptides, as well as molecules that naturally occur in the human body. Its products include alkaline phosphatase for treatment of acute kidney injury and ulcerative colitis; and immune response amplifying peptide hLF1-11 for the treatment of drug resistant hospital acquired infections. The company was founded in 2000 and is headquartered in Bunnik, the Netherlands.
- DAMAE Medical — Damae Medical is a Paris, France-based medtech company. It has developed a medical device capable of seeing biological tissues in depth, at a cellular level and in vivo. This innovative optical imaging technology will especially allow dermatologists to evaluate in a precise, efficient and rapid way malignancy of tumors by a simple contact with thesurface of the skin. DAMAE Medical’s mission is to put the great power of bio-photonics at the service of opening new opportunities in medical imaging and diagnosis.
International research Institute that pursues to study and eradicate Leukaemia, Lymphoma and other Hemopathies.
Show more...Investment focus
- Industry: Life Science, Biotechnology
- Stage:Seed
- Geography: Spain
Investor stats
- Total investments: 2
- Round size: Seed $3.4M–$7.3M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- OneChain Immunotherapeutics — CAR-T Immunotherapies against hematological malignancies
Demium is a talent investment company founded in Spain in 2013 with the aim of supporting the best professionals and helping them to carry out successful projects, always with an eminently digital and technological component. In November 2020, it's asset management company, Demium Capital, started operating with a first €50M fund to invest inmore than 75 early-stage startups per year (pre-seed/seed), becoming the most active venture capital fund in Spain. Startups such as Hannun, Voicemod, Swipcar, Citibox, Singularu or Landbot, among others have been created in the incubator. The company is present in five countries: Spain, Portugal, Poland, Ukraine and Czech Republic
Show more...Investment focus
- Industry: Software, FinTech, Health Care
- Stage:Pre-Seed, Seed, Series A
- Geography: Spain, Portugal, Poland
Investor stats
- Total investments: 84
- Round size: Seed $110k–$3.1M; Pre-Seed $110k–$574k
- Lead/follow: 61% lead, 39% follow
- Last fund: May invest from a new fund soon — raised $52M in 2020
Portfolio highlights
- Rauda AI — Rauda is an artificial intelligence platform specialized in automating customer service with the best customer experience. Take a quantum leap in productivity, reduce costs and improve customer satisfaction with the power of generative artificial intelligence.
- Aino — AI-powered site analysis for real estate professionals. Generate feasibility studies with quantified metrics, maps, cost estimates, and zoning insights in minutes, no GIS or coding required.
- Orbital Paradigm —
Grupo Ferrer International is a privately-held European R&D-based pharmaceutical company headquartered in Barcelona. It is active in the pharmaceutical, health, fine chemicals and food sectors in Europe, Latin America, Africa, the Middle East, Asia and the United States. In total, Ferrer's human health care products are commercialized inmore than 95 countries, through 24 international affiliates (including joint ventures) and 70 partners and distributors. Ferrer carries out activities throughout the full pharmaceutical value chain, from R&D to international marketing, including the fine chemical development and the manufacturing of both raw materials and finished pharmaceuticals. Its research centers in Spain and Germany, and manufacturing sites in Europe and Latin America cover the pharmaceutical, diagnostics, vaccine, fine chemical, food and feed sectors.
Show more...Investment focus
- Industry: Biotechnology, Wellness, Biopharma
- Stage:Series A
- Geography: Spain
Investor stats
- Total investments: 2
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Venter Pharma SL — Venter Pharma is a biotech company that aims to develop products in the field of gastroenterology to help patients and professionals.It arises on the bases of some research work carried out by PhD. Juan José Aragón Reyes and Alfonso Fernández Mayoralas in the Autonomous University of Madrid and Spanish National Research Council respectively.Venter Pharma focuses on the study of solutions for digestive pathologies, with especial attention to high population prevalence disorders such as lactose intolerance or inflammatory illnesses. Venter Pharma develops innovative products to make a clinical diagnosis easier, simpler and more effective. LacTEST®, is a new diagnosic drug for the diagnosis of lactose intolerance based on a new active substance: Gaxilose
- ABAC Therapeutics — Situs resmi di Indonesia yang menghadirkan game dari PG Soft & Pragmatic Play Paling Gacor , Gampang JP Disini, surga77 memberikan akses ke permainan slot berkualitas tinggi dengan RTP yang terbukti akurat. Semua game yang disediakan di situs ini memiliki tingkat kemenangan yang transparan dan mudah diprediksi. surga77 memastikan bahwa setiap permainan dioperasikan dengan standar tertinggi dalam hal keamanan dan keadilan. Dengan berbagai fitur menarik dan berbagai pilihan permainan, pemain dapat menikmati pengalaman bermain slot yang menyenangkan dan menguntungkan. Ditambah dengan sistem transaksi yang cepat dan layanan pelanggan yang responsif, surga77 adalah tempat yang sempurna untuk para penggemar slot di Indonesia yang ingin bermain dengan nyaman.
Easo Ventures es una Sociedad de Capital Riesgo Vasca y Privada, cuyo objetivo es invertir en Startups y PYMES con proyectos de crecimiento.
Show more...Investment focus
- Industry: Software, Health Care, Manufacturing
- Stage:Seed, Venture - Series Unknown
- Geography: Spain, Switzerland
Investor stats
- Total investments: 76
- Round size: Seed $266k–$3.2M; Venture - Series Unknown $54k–$5.3M
- Lead/follow: 26% lead, 74% follow
Portfolio highlights
- Energiot — Energiot specialized engineering service in energy harvesting, self-powered devices, wireless sensor networks.
- DYNAMICS VR — Dynamics VR provides rehab software for clinics to tackle musculoskeletal pain and movement impairments caused by brain trauma.
- DARWIN Biomed — Biomedical Engineering
Kinled was founded in 1980 to retain the investment assets of the Aisher family.In 1990, the investment focus shifted to a portfolio of early stage investments applying Kinled’s company development experience alongside the endurance and passion of family owned investments together with the strategic focus of venture capitalists.Since then,Kinled has taken 8 companies to public markets and many more to successful trade sales at significant multiples.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Series A
- Geography: United Kingdom, United States, Switzerland
Investor stats
- Total investments: 133
- Round size: Seed $500k–$11M; Series A $2M–$43M
- Lead/follow: 4% lead, 96% follow
Portfolio highlights
- Esper — Esper is the first cloud-based platform to help governments proactively manage public policy with better data and transparency.
- Varda — Expanding the economic bounds of humankind with the world's first orbital manufacturing & reentry platform.
- PreComb — PreComb develops technologies to optimally adapt the therapies to each patient for difficult to treat cancers to increase the success rates in cancer therapy. Only an efficient use of healthcare resources can lead to a maximum improvement in the quality of life of patients.
Biotech Investor funding in Spain at a glance
Stats across 539 deals from 437 investors.
Access all 437 investors in Spain Biotech startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Biotech Investors in Spain investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 437 investors investing in Spain Biotech startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!